Luciano J. Costa

Luciano Costa practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Luciano Costa's NPI, 1477606309, was assigned on January 22, 2007. Luciano Costa graduated from Universidade de Sao Paulo Faculty of Medicine in 1998. Luciano Costa's Alabama license number on file is 33450.

Luciano Costa's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Luciano Costa's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Luciano Costa is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Luciano Costa to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Luciano Costa practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Luciano Costa's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Luciano Costa is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Luciano Costa's licenses on file in 4 states: Alabama, South Carolina, Michigan and Minnesota.

Dmand AI lists lymphoma and multiple myeloma among the conditions Luciano Costa treats.

CMS data shows 978 Medicare services from Luciano Costa across 6 procedure codes in 2024, for 253 Medicare patients. Medicare paid $61,668 for them.

CMS counts 253 Medicare patients who saw Luciano Costa in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 11% are also on Medicaid. Their average risk score is 3.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Luciano Costa's median patient age at 68, with 48% women.

In 2024, Luciano Costa wrote 3,229 Medicare Part D claims for 261 patients. 84% of them were for generic drugs. CMS names the drug for 2,857 of them, across 53 drugs with 11 or more claims each, at $6,969,346 in total drug cost. In 2023, CMS named 2,558 claims across 54 drugs.

Luciano Costa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Luciano Costa as offering telehealth.

Dmand AI links 172 papers to Luciano Costa, published from 2004 to 2025. 2024 was the busiest year, with 18. The most frequent topics are Multiple Myeloma, Hematopoietic Stem Cell Transplantation and Antineoplastic Combined Chemotherapy Protocols. Luciano Costa has published most often in Am J Hematol. Luciano Costa's most frequent co-authors are Susan Bal, Kelly N. Godby, MD and Smith Giri.

Dmand AI links Luciano Costa to 7 clinical trials, 3 of them phase 2 studies. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Anemia, Aplastic and Bronchiolitis Obliterans Syndrome. University of Alabama at Birmingham sponsors the most, 3. Open Payments lists research payments to Luciano Costa that name 1 trial.

CMS Open Payments shows 384 general payments to Luciano Costa from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Sanofi and Genzyme US Companies paid the most, $169,843. It also lists 17 research payments totaling $21,941 from 2016 to 2025, naming 1 clinical trial.

Luciano Costa graduated from Universidade de Sao Paulo Faculty of Medicine in 1998.

Luciano Costa is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.